Boothbay Fund Management, LLC Seres Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $170,740 - $351,237	-48,783 Reduced 77.78%	13,937 $89,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $65,736 - $185,524	-24,347 Reduced 27.96%	62,720 $215,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $7,963 - $11,173	-1,264 Reduced 1.43%	87,067 $620,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $163,948 - $311,284	27,234 Added 44.58%	88,331 $736,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $110,848 - $458,825	20,302 Added 49.77%	61,097 $425,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $720,439 - $1.18 Million	40,795 New	40,795 $840,000
Q4 2020 Feb 12, 2021	SELL	$23.25 - $37.73 $354,144 - $574,703	-15,232 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $13,583 - $104,383	3,632 Added 31.31%	15,232 $431,000
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $35,264 - $71,920	11,600 New	11,600 $55,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.